Key Dates

Related Announcements

RFA-HG-22-027 - Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

This is a Notice to update the Page Limits instructions for Funding Opportunity Announcement (FOA), RFA-HG-22-027 - Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional). The changes are noted in “bold italics.”

Currently Reads:

Part 2. Section IV. Application and Submission Information; 2. Content and Form of Application Submission; Page Limitations.

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Modified to Read (changes shown in bold italics):

Part 2. Section IV. Application and Submission Information; 2. Content and Form of Application Submission; Page Limitations.

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed with the following exception: The Research Strategy for the UG3/UHS is limited to 30 pages.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Ebony Madden
National Human Genome Research Institute (NHGRI)
Telephone: 301-503-5620
Email: [email protected]